Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes.

The role of the cellular immune response in human T-cell leukemia virus type I (HTLV-I) infection is not fully understood. A persistently activated cytotoxic T lymphocyte (CTL) response to HTLV-I is found in the majority of infected individuals. However, it remains unclear whether this CTL response is protective or causes tissue damage. In addition, several observations paradoxically suggest that HTLV-I is transcriptionally silent in most infected cells and, therefore, not detectable by virus-specific CTLs. With the use of a new flow cytometric procedure, we show here that a high proportion of naturally infected CD4+ peripheral blood mononuclear cells (PBMC) (between 10% and 80%) are capable of expressing Tax, the immunodominant target antigen recognized by virus-specific CTLs. Furthermore, we provide direct evidence that autologous CD8+ T cells rapidly kill CD4+ cells naturally infected with HTLV-I and expressing Tax in vitro by a perforin-dependent mechanism. Consistent with these observations, we observed a significant negative correlation between the frequency of Tax(11-19)-specific CD8+ T cells and the percentage of CD4+ T cells in peripheral blood of patients infected with HTLV-I. Those results are in accordance with the view that virus-specific CTLs participate in a highly efficient immune surveillance mechanism that persistently destroys Tax-expressing HTLV-I-infected CD4+ T cells in vivo. (Blood. 2000;95:1386-1392)

[1]  H. Inoko,et al.  Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells , 1992, Journal of virology.

[2]  S. Izumo,et al.  Analysis Of Htlv-I Proviral Load In 202 Ham/Tsp Patients And 243 Asymptomatic Htlv-I Carriers: High Proviral Load Strongly Predisposes To Ham/Tsp , 1998 .

[3]  G. Lecatsas,et al.  Human T-lymphotropic virus type I-associated myelopathy , 1991 .

[4]  D. Kioussis,et al.  Contribution of  Virus-specific CD8+ Cytotoxic T Cells to Virus Clearance or Pathologic Manifestations of Influenza Virus Infection in a T Cell Receptor Transgenic Mouse Model , 1998, The Journal of experimental medicine.

[5]  G. Boiteau,et al.  J. Virol. Methods , 1996, Journal of Virological Methods.

[6]  S. Jacobson,et al.  Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection. , 1998, Journal of immunology.

[7]  馬止 裕 Close association between interleukin-2 receptor mRNA expression and human T cell leukemia/lymphoma virus type I viral RNA expression in short-term cultured leukemic cells from adult T cell leukemia patients , 1989 .

[8]  G. de Thé,et al.  An HTLV-I vaccine: why, how, for whom? , 1993, AIDS research and human retroviruses.

[9]  Y. Itoyama,et al.  Expression of HTLV-I antigen in cultured peripheral blood mononuclear cells from patients with HTLV-I associated myelopathy , 1988, Journal of the Neurological Sciences.

[10]  J. Weber,et al.  Quantification of proviral DNA load in human T-cell leukaemia virus type I infections. , 1998, Journal of virological methods.

[11]  P Rudge,et al.  In vivo cellular tropism of human T-cell leukemia virus type 1 , 1990, Journal of virology.

[12]  M. Nowak,et al.  Genetic control and dynamics of the cellular immune response to the human T-cell leukaemia virus, HTLV-I. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[13]  E. Sato,et al.  Apoptosis of T Lymphocytes in the Spinal Cord Lesions in HTLV‐l-Associated Myelopathy: A Possible Mechanism to Control Viral Infection in the Central Nervous System , 1994, Journal of neuropathology and experimental neurology.

[14]  Y. Tanaka,et al.  Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. , 1999, Journal of neurovirology.

[15]  P. Höllsberg Mechanisms of T-Cell Activation by Human T-Cell Lymphotropic Virus Type I , 1999, Microbiology and Molecular Biology Reviews.

[16]  T. Sugimura,et al.  Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Zinkernagel,et al.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system , 1974, Nature.

[18]  S. Yonehara,et al.  Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. , 1996, Journal of immunology.

[19]  C. Bangham,et al.  Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. , 1992, Virology.

[20]  D. Hafler,et al.  Variable immortalizing potential and frequent virus latency in blood-derived T-cell clones infected with human T-cell leukemia virus type I. , 1997, Blood.

[21]  A. Fauci,et al.  Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease , 1990, Nature.

[22]  Philip J. R. Goulder,et al.  Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.

[23]  J. Weber,et al.  Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously , 1994, Journal of virology.

[24]  B. Cullen Regulation of human immunodeficiency virus replication. , 1991, Annual review of microbiology.

[25]  A. Haase,et al.  Human T‐lymphotropic virus type I‐associated myelopathy and tax gene expression in CD4+ T lymphocytes , 1996, Annals of neurology.

[26]  A. Kermode,et al.  High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis. , 1996, Virology.

[27]  T. Uchiyama Human T cell leukemia virus type I (HTLV-I) and human diseases. , 1997, Annual review of immunology.

[28]  M. Nakagawa,et al.  Immunocytochemical Analysis of the Cellular Infiltrate in the Spinal Cord Lesions in HTLV‐I‐Associated Myelopathy , 1993, Journal of neuropathology and experimental neurology.

[29]  D. Hafler,et al.  Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy. , 1999, Journal of immunology.

[30]  M. Nowak,et al.  HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. Zinkernagel,et al.  Role of virus and host variables in virus persistence or immunopathological disease caused by a non-cytolytic virus. , 1995, The Journal of general virology.

[32]  Y. Koyanagi,et al.  Effect of human serum anti‐htlv antibodies on viral antigen induction in In vitro cultured peripheral lymphocytes from adult T‐CELL leukemia patients and healthy virus carriers , 1985, International journal of cancer.

[33]  Yuetsu Tanaka,et al.  Monoclonal antibody defining tax protein of human T-cell leukemia virus type-I. , 1989, The Tohoku journal of experimental medicine.

[34]  R. Gallo,et al.  Human T-cell leukemia-lymphoma virus type I (HTLV-I) expression in fresh peripheral blood mononuclear cells from patients with tropical spastic paraparesis/HTLV-I-associated myelopathy , 1991, Journal of virology.